FDA approval of Casgevy and Lyfgenia: a dual breakthrough in gene therapies for sickle cell disease

Ann Med Surg (Lond). 2024 Jul 25;86(9):4966-4968. doi: 10.1097/MS9.0000000000002409. eCollection 2024 Sep.

Authors

Zainab Syyeda Rahmat¹, Mohammad Haris Ali², Muhammad Talha², Md Al Hasibuzzaman³

Affiliations

¹ Faculty of Medicine, Dow Medical College, Dow University of Health Sciences, Karachi.
² Shaikh Khalifa Bin Zayed Al-Nahyan Medical and Dental College, Lahore, Pakistan.
³ Institute of Nutrition and Food Science, University of Dhaka, Dhaka, Bangladesh.

No abstract available

Publication types

Editorial